Profile avatar
grumpyparticle.bsky.social
Hiking/nonsense/IC/SC2-avoidance/QNFT-software. [Somewhere in Switzerland.] Follows don't reflect beliefs/principles.
147 posts 41 followers 98 following
Regular Contributor
Active Commenter
Posts 13 Comments 37

A 2024 manufacturer-funded study suggests that Bimervax XBB produces a similar response to Comirnaty XBB. Which means: Bimervax might be a reasonable option *if* they can manage to produce updates and get them approved sooner...

submitted 22 hours ago • 1 comment

Are Lucira preempting upcoming EUA changes? (Or am I just a conspiracy theorist?)

submitted 9 days ago • 1 comment

I had been wondering why OSHA deleted their APF guide:

submitted 10 days ago • 0 comments

The Swiss cheese model - updated for 2025. Slightly closer to reality than the old one.

submitted 13 days ago • 1 comment

QNFT per-exercise sample times by protocol:

submitted 19 days ago • 1 comment

I was only able to find one country in the intersection of "countries that require fit-testing" and "countries that consider FFP3 to offer superior protection to FFP2" (or local equivalent).

submitted 20 days ago • 1 comment

Have a great weekend everyone! Mine mightn't be.

submitted 20 days ago • 0 comments

<Product name omitted for my own safety> (JK, no one's paying any attention.)

submitted 21 days ago • 1 comment

Trying to be a "hobby scientist" is frustrating. Here's an interesting paper... oh, I have to pay an arm and a leg to access it for 48h!?

submitted 29 days ago • 0 comments

Paxlovid-Käufe nach Land, c.a. Mitte-2022: die Schweiz und Irland bilden die einsamen Schlusslichter. GB hat pro-Kopf 30x mehr als die CH bestellt, DE 9x mehr.

submitted 32 days ago • 1 comment

A thread infection prevention, and iMasks ... The frequent weld failures in Standart UA's iMasks have been discussed up and down Twitter and BSky. Having done my own analysis a bit over a year ago, I decided to get a new batch and see whether the design had been improved.

submitted 40 days ago • 1 comment

Next bus? Next season.

submitted 41 days ago • 0 comments

Das Luzerner Kantonsspital hat seine Internen Paxlovid/Remdesivir Richtlinien verschärft: seit November '24 ist eine Früh-Therapie nur noch bei schwerer Immundefizienz «meist indiziert» (weitere Risikogruppen nur bei fehlender Impfung, falls schon anderweitig Hospitalisiert).

submitted 48 days ago • 1 comment